Search information
Ownership
Exclude Filing Types
WORK Medical Technology Group LTD
Companies
Tables in SEC filings
Source
For the Years Ended | ||||||||||||
September 30, | ||||||||||||
2024 | 2023 | 2022 | ||||||||||
Net revenue | $ | 11,506,440 | $ | 13,565,951 | $ | 19,711,290 | ||||||
Cost of revenue | (8,638,054) | (9,422,967) | (15,292,498) | |||||||||
Gross profit | 2,868,386 | 4,142,984 | 4,418,792 | |||||||||
Selling expenses | (2,053,019) | (1,567,385) | (1,032,685) | |||||||||
General and administrative expenses | (4,558,041) | (1,861,728) | (2,563,879) | |||||||||
Research and development expenses | (302,511) | (301,644) | (183,900) | |||||||||
Total operating expenses | (6,913,571) | (3,730,757) | (3,780,464) | |||||||||
(Loss) income from operations | (4,045,185) | 412,227 | 638,328 | |||||||||
Total other income (loss), net | 379,485 | (301,838) | 475,233 | |||||||||
(Loss) income before income tax | (3,665,700) | 110,389 | 1,113,561 | |||||||||
Income tax benefit (expense) | 125,291 | (47,006) | (169,435) | |||||||||
Net (loss) income | (3,540,409) | 63,383 | 944,126 |
Ordinary Shares Beneficially Owned | Voting Power | |||||||||||
Number | % | % | ||||||||||
Directors and Officers:(1) | ||||||||||||
Shuang Wu | — | — | — | |||||||||
Baiming Yu(2) | 6,250,000 | 42.83 | % | 42.83 | % | |||||||
Ningfang Liang | — | — | — | |||||||||
Robert Johnson | — | — | — | |||||||||
Zhenguo Wu | — | — | — | |||||||||
Xiaoyang Li | — | — | — | |||||||||
5% Shareholders(3): | ||||||||||||
LWY GROUP LTD(2) | 6,250,000 | 42.83 | % | 42.83 | % |
As of September 30, | ||||||||||||
2024 | 2023 | 2022 | ||||||||||
Shuang Wu | $ | 1,424,989 | $ | 795,243 | $ | - | ||||||
Hangzhou Qingniu | 855,618 | 1,294,296 | 429,347 | |||||||||
Hangzhou Shuige | 421,092 | - | - | |||||||||
Qijia Yu | 5,437 | - | - | |||||||||
Huiyu Chuanggu | - | 1,453,583 | - | |||||||||
Baiming Yu | - | 683,376 | 160,405 | |||||||||
Liwei Zhang | - | 11,184 | 70,514 | |||||||||
Baicheng Zhang | - | - | 46,012 | |||||||||
Total | $ | 2,707,136 | $ | 4,237,682 | $ | 706,278 |
For the years ended | ||||||||||||
September 30, | ||||||||||||
2024 | 2023 | 2022 | ||||||||||
Net revenue from third parties | $ | 10,929,070 | $ | 12,501,615 | $ | 19,498,315 | ||||||
Net revenue from related party | 577,370 | 1,064,336 | 212,975 | |||||||||
Cost of revenues from third parties | (8,346,419) | (8,596,872) | (15,197,213) | |||||||||
Cost of revenue from related party | (291,635) | (826,095) | (95,285) | |||||||||
Gross profit | 2,868,386 | 4,142,984 | 4,418,792 | |||||||||
Operating expenses: | ||||||||||||
Selling expenses | (2,053,019) | (1,567,385) | (1,032,685) | |||||||||
General and administrative expenses | (4,558,041) | (1,861,728) | (2,563,879) | |||||||||
Research and development expenses | (302,511) | (301,644) | (183,900) | |||||||||
Total operating expenses | (6,913,571) | (3,730,757) | (3,780,464) | |||||||||
Other (loss) income: | ||||||||||||
Interest expense | (557,571) | (392,741) | (352,968) | |||||||||
Interest income | 11,727 | 25,417 | 1,969 | |||||||||
Government subsidies | 346,571 | 74,232 | 1,186,641 | |||||||||
Other income(expenses), net | 578,758 | (8,746) | (360,409) | |||||||||
Total other income(loss) | 379,485 | (301,838) | 475,233 | |||||||||
(Loss) income before income tax expense | (3,665,700) | 110,389 | 1,113,561 | |||||||||
Income tax benefit (expense) | 125,291 | (47,006) | (169,435) | |||||||||
Net (loss) income | $ | (3,540,409) | $ | 63,383 | $ | 944,126 | ||||||
Net (loss) income attributable to non-controlling interest | (48,091) | (48,647) | 78,916 | |||||||||
Net (loss) income attributable to ordinary shareholders | $ | (3,492,318) | $ | 112,030 | $ | 865,210 | ||||||
Other comprehensive loss: | ||||||||||||
Foreign currency translation adjustment | 453,181 | (268,068) | (1,147,710) | |||||||||
Total comprehensive loss | (3,087,228) | (204,685) | (203,584) | |||||||||
Total comprehensive income (loss) attributable to non-controlling interests | 136,727 | (80,165) | (164,329) | |||||||||
Total comprehensive loss attributable to shareholders | $ | (3,223,955) | $ | (124,520) | $ | (39,255) | ||||||
Weighted average number of Ordinary Shares | ||||||||||||
Basic and Diluted* | 12,705,011 | 12,500,000 | 12,500,000 | |||||||||
Basic and diluted (loss) earnings per ordinary share | (0.27) | 0.01 | 0.07 |
For the years ended | ||||||||||||
September 30, | ||||||||||||
2024 | 2023 | 2022 | ||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net (loss) income | $ | (3,540,409) | $ | 63,383 | $ | 944,126 | ||||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Depreciation and amortization | 1,410,452 | 1,603,129 | 3,258,267 | |||||||||
Inventories write-down | 762 | 18,320 | (117,327) | |||||||||
Gain (loss) on disposal of equipment | 42,504 | 8,089 | (10,871) | |||||||||
Allowance for credit loss | 12,157 | 149,503 | 1,108,999 | |||||||||
Deferred tax benefits | (46,044) | (94,533) | (314,008) | |||||||||
Changes in assets and liabilities: | ||||||||||||
Accounts receivable – third parties | 1,815,361 | (131,950) | (4,234,997) | |||||||||
Accounts receivable – related party | — | — | 275,993 | |||||||||
Advance to suppliers | (1,061,321) | 977,318 | (191,774) | |||||||||
Amount due (from) to related parties | 1,775,923 | (3,964,077) | 743,490 | |||||||||
Inventories | 1,576,799 | (400,544) | 2,053,675 | |||||||||
Operating lease liabilities | (2,029) | (51,755) | (5,212) | |||||||||
Prepaid expenses and other current assets | 293,683 | 1,291,145 | (194,118) | |||||||||
Accounts payable | (2,553,902) | 864,585 | (5,822,547) | |||||||||
Income taxes payable | (250,423) | 136,508 | 81,428 | |||||||||
Deferred revenue | (176,969) | 52,245 | (751,375) | |||||||||
Accrued expenses and other liabilities | (1,524,631) | 1,688,370 | 917,303 | |||||||||
Net cash (used in) provided by operating activities | (2,228,087) | 2,209,736 | (2,258,948) | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Purchase of intangible assets | (33,313) | (127,913) | — | |||||||||
Purchase of property and equipment | (9,225,094) | (455,391) | (2,012,546) | |||||||||
Proceed from disposal of property and equipment | 194,328 | — | 601,760 | |||||||||
Cash acquired from Shanghai Saitumofei | — | — | 63,621 | |||||||||
Net cash used in investing activities | (9,064,079) | (583,304) | (1,347,165) | |||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Proceeds from initial public offering | 7,373,839 | — | — | |||||||||
Cash deposited in escrow account | (400,000) | — | — | |||||||||
Contributions from non-controlling interest | 2,767,032 | — | — | |||||||||
Proceeds from short-term borrowings | 13,394,778 | 9,107,082 | 7,248,367 | |||||||||
Repayments of short-term borrowings | (9,369,404) | (6,000,791) | (7,248,367) | |||||||||
Loans to related parties | (4,574,088) | (5,669,834) | (9,493,121) | |||||||||
Repayment from related parties | 5,477,054 | 5,891,373 | 13,260,930 | |||||||||
Loans to third parties | (1,133,656) | (2,723,935) | (1,030,628) | |||||||||
Repayment from loans to third parties | 2,734,478 | 23,562 | 829,042 | |||||||||
Payment of offering cost | (613,009) | (1,356,176) | — | |||||||||
Net cash provided by (used in) financing activities | 15,657,024 | (728,719) | 3,566,223 | |||||||||
Effect of exchange rate changes | 555,464 | (33,852) | (59,819) | |||||||||
Net increase (decrease) in cash and restricted cash | 4,920,322 | 863,861 | (99,709) | |||||||||
Cash, cash equivalents, and restricted cash, at beginning of year | 1,637,283 | 773,422 | 873,131 | |||||||||
Cash, cash equivalents and restricted cash, at end of year | $ | 6,557,605 | $ | 1,637,283 | $ | 773,422 | ||||||
Reconciliation to amounts on consolidated balance sheets: | ||||||||||||
Cash and cash equivalents | 6,557,605 | 1,596,096 | 731,178 | |||||||||
Restricted cash | - | 41,187 | 42,244 | |||||||||
Total cash, cash equivalents and restricted cash shown in the statement of cash flows | 6,557,605 | 1,637,283 | 773,422 | |||||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||||||
Income taxes paid | 9,973 | $ | 160,162 | $ | 340,024 | |||||||
Interest paid | 543,753 | $ | 312,035 | $ | 312,282 |